These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3351153)

  • 21. Long-term antiarrhythmic therapy with cibenzoline.
    Mohiuddin SM; Hilleman DE; Esterbrooks D; Mooss AN; Stengel LA
    J Clin Pharmacol; 1987; 27(5):400-6. PubMed ID: 3693585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind placebo-controlled evaluation of propafenone in suppressing ventricular ectopic activity.
    Hodges M; Salerno D; Granrud G
    Am J Cardiol; 1984 Nov; 54(9):45D-50D. PubMed ID: 6388303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid suppression of complex ventricular arrhythmias with high-dose oral amiodarone.
    Mostow ND; Vrobel TR; Noon D; Rakita L
    Circulation; 1986 Jun; 73(6):1231-8. PubMed ID: 3698254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac and antiarrhythmic effects of imipramine in patients with ventricular arrhythmias.
    Giardina EG
    Biomed Pharmacother; 1984; 38(3):128-30. PubMed ID: 6478051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of chronic ventricular arrhythmias with propranolol.
    Woosley RL; Kornhauser D; Smith R; Reele S; Higgins SB; Nies AS; Shand DG; Oates JA
    Circulation; 1979 Oct; 60(4):819-27. PubMed ID: 476887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
    Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP
    Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mexiletine: an effective antiarrhythmic drug for treatment of ventricular arrhythmias in congenital heart disease.
    Moak JP; Smith RT; Garson A
    J Am Coll Cardiol; 1987 Oct; 10(4):824-9. PubMed ID: 3655149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atenolol for ventricular ectopy: a dose-response study.
    Fenster PE; Reynolds D; Horwitz LD; Morrison D; Goldman S; Thadani U; Lazzara R; Serokman R; Marcus FI
    Clin Pharmacol Ther; 1987 Jan; 41(1):118-23. PubMed ID: 3802701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recainam, a potent new antiarrhythmic agent: effects on complex ventricular arrhythmias.
    Anastasiou-Nana MI; Anderson JL; Hampton EM; Nanas JN; Heath BM
    J Am Coll Cardiol; 1986 Aug; 8(2):427-35. PubMed ID: 3734265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral amiodarone in high-risk ventricular arrhythmias.
    Toruncha A; García-Barreto D; González-Gómez A; Llerena L; Sellén J; Ramos-Emperador C; Cabrera-Alonso C; Hernández-Cañero A
    Cor Vasa; 1982; 24(5):354-64. PubMed ID: 7172689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relation of the kinetics of pirmenol to its antiarrhythmic efficacy.
    Johnson BF; Haffajee CI; Woodman T; Sloan KL
    J Clin Pharmacol; 1988 May; 28(5):401-5. PubMed ID: 3392237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias.
    Anastasiou-Nana MI; Gilbert EM; Miller RH; Singh S; Freedman RA; Keefe DL; Saksena S; MacNeil DJ; Anderson JL
    Am J Cardiol; 1991 Mar; 67(6):511-6. PubMed ID: 1705386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study.
    Anderson JL; Lutz JR; Nappi JM
    Am J Cardiol; 1984 Feb; 53(4):522-7. PubMed ID: 6198894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term antiarrhythmic pharmaco-therapy guided by Holter monitoring in patients with malignant ventricular arrhythmias and ischemic heart disease.
    Trusz-Gluza M; Gasior Z; Wnuk-Wojnar AM; Filipecki A; Szydło K; Giec L
    Mater Med Pol; 1992; 24(4):229-32. PubMed ID: 1308049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cibenzoline for treatment of ventricular arrhythmias: a double-blind placebo-controlled study.
    Kostis JB; Krieger S; Moreyra A; Cosgrove N
    J Am Coll Cardiol; 1984 Aug; 4(2):372-7. PubMed ID: 6376595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of flecainide in patients with stable ventricular ectopic beats. Multicenter trial of the Italian Study Group on the Electrophysiology of Arrhythmias.
    G Ital Cardiol; 1989 Apr; 19(4):360-70. PubMed ID: 2502464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of flecainide in the management of ventricular arrhythmias: comparative study with amiodarone.
    Dubner SJ; Elencwajg BD; Palma S; Mendelzon R; Ramos A; Bertolasi CA
    Am Heart J; 1985 Mar; 109(3 Pt 1):523-8. PubMed ID: 3883728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Oshrain C; Steele PP
    Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias.
    Browne KF; Prystowsky EN; Zipes DP; Chilson DA; Heger JJ
    J Am Coll Cardiol; 1984 Mar; 3(3):857-64. PubMed ID: 6693656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.